These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21658936)

  • 1. Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma.
    Jenkins P; Milliner R; Salmon C
    Eur J Cancer; 2011 Sep; 47(14):2143-9. PubMed ID: 21658936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
    Bottomley A; Coens C; Efficace F; Gaafar R; Manegold C; Burgers S; Vincent M; Legrand C; van Meerbeeck JP;
    J Clin Oncol; 2007 Dec; 25(36):5770-6. PubMed ID: 18089874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.
    Xia H; Karasawa K; Hanyu N; Chang TC; Okamoto M; Kiguchi Y; Kawakami M; Itazawa T
    Int J Hyperthermia; 2006 Nov; 22(7):613-21. PubMed ID: 17079218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
    Bottomley A; Gaafar R; Manegold C; Burgers S; Coens C; Legrand C; Vincent M; Giaccone G; Van Meerbeeck J; ;
    J Clin Oncol; 2006 Mar; 24(9):1435-42. PubMed ID: 16446322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of radiotherapy in the treatment of malignant pleural mesothelioma.
    Waite K; Gilligan D
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):182-7. PubMed ID: 17359904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma?
    Sharif S; Zahid I; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1040-5. PubMed ID: 21388982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of radiotherapy in the treatment of malignant pleural mesothelioma in the chemotherapy era.
    Johnston R; Harrison C; Eakin R; Stewart D; Stranex S; McAleese J
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):630-1. PubMed ID: 17669639
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of conservative (palliative) care-only in the management of advanced malignant pleural mesothelioma.
    Levy A; Assouline A; Rivera S; Chargari C; Tai P
    Anticancer Res; 2012 Sep; 32(9):4025-7. PubMed ID: 22993354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-pathological prognostic factors in malignant pleural mesothelioma].
    Nakano K; Shiota Y; Ono T; Taniyama K; Hiramoto T; Yamakido M
    Nihon Kokyuki Gakkai Zasshi; 2007 Feb; 45(2):153-9. PubMed ID: 17352172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
    Cao KJ; Cui NJ
    Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.
    van Meerbeeck JP; Gaafar R; Manegold C; Van Klaveren RJ; Van Marck EA; Vincent M; Legrand C; Bottomley A; Debruyne C; Giaccone G; ;
    J Clin Oncol; 2005 Oct; 23(28):6881-9. PubMed ID: 16192580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma.
    Watzka SB; Setinek U; Stubenberger EB; Tötsch M; Dekan G; Marcher M; Fleck T; Müller MR
    Eur J Cardiothorac Surg; 2011 Feb; 39(2):180-4. PubMed ID: 20580243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose.
    Ceresoli GL; Chiti A; Zucali PA; Rodari M; Lutman RF; Salamina S; Incarbone M; Alloisio M; Santoro A
    J Clin Oncol; 2006 Oct; 24(28):4587-93. PubMed ID: 17008700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?
    Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA
    Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.